Key facts
- This page summarizes Cory Randall Ellspermann's Form 4 filing for Inmune Bio, Inc. (INMB).
- 10 reported transactions and 10 derivative rows are listed below.
- Accepted by SEC: 18 Nov 2025, 17:25.
Cory Randall Ellspermann - 18 Nov 2025 Form 4 Insider Report for Inmune Bio, Inc. (INMB)
- Reporting relationship
- Interim CFO
- Issuer ticker
- INMB
- Reported as of
- 18 Nov 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Nov 2025, 17:25:54 UTC
- Prior SEC filing
- 18 Aug 2025
- Next SEC filing
- 02 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cory Randall Ellspermann
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Cory Randall Ellspermann filed Form 4 for Inmune Bio, Inc. (INMB) on 18 Nov 2025.
Change
- Previous filing in this sequence was filed on 18 Aug 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002082083
Primary reporting owner
Ellspermann Cory Randall
- Relationship
- Interim CFO
- Address
- C/O INMUNE BIO INC., 225 NE MIZNER BLVD., SUITE 640, BOCA RATON
- Signature
- /s/ Cory Randall Ellspermann
- Signature date
- 18 Nov 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INMB
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -75,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $3.91
- Footnotes
- F1, F2
INMB
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +75,000
- Change %
- Price
- Shares after
- 75,000
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $1.50
- Footnotes
- F1, F2
INMB
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -40,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $21.06
- Footnotes
- F1, F2
INMB
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +40,000
- Change %
- Price
- Shares after
- 40,000
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $1.50
- Footnotes
- F1, F2
INMB
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -30,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $7.92
- Footnotes
- F1, F2
INMB
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +30,000
- Change %
- Price
- Shares after
- 30,000
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $1.50
- Footnotes
- F1, F2
INMB
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -70,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $5.05
- Footnotes
- F1, F2
INMB
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +70,000
- Change %
- Price
- Shares after
- 70,000
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 70,000
- Exercise price
- $1.50
- Footnotes
- F1, F2
INMB
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -30,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $9.92
- Footnotes
- F1, F2
INMB
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +30,000
- Change %
- Price
- Shares after
- 30,000
- Date
- 18 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $1.50
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Effective as of November 18, 2025 (the "Repricing Date"), the Issuer's stockholders approved a one-time repricing of certain outstanding stock options (the "Repriced Options") granted under the Issuer's 2017 Stock Incentive Plan (the "2017 Plan"), 2019 Stock Incentive Plan (the "2019 Plan"), and Second Amended and Restated 2021 Stock Incentive Plan (as may be amended, restated or otherwise modified from time to time in accordance with its terms, the "2021 Plan") , which reduced the per share exercise price of each Repriced Option to $1.50, representing the closing price of the Issuer's common stock on The Nasdaq Capital Market on the Repricing Date (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the Repriced Options, including, without limitation, any provisions with respect to vesting and term of the Repriced Options, remain in full force and effect.
Footnote F2
This stock option award was issued pursuant to the 2017 Plan, 2019 Plan and/or the 2021 Plan, as applicable, and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form 4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.